In vitro effects of Antiphospholipid Syndrome-IgG fractions and Human Monoclonal Antiphospholipid IgG Antibody on Human Umbilical Vein Endothelial cells and Monocytes: Promotion of procoagulant activity and inflammation

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 805-813

  Clemens, Natascha ^a   Frauenknecht, Katrin ^b   Katzav, Aviva ^a   Sommer, Clemens ^b   Von Landenberg, Philipp ^b  

^a Institut fur Klinische Chemie und Laboratoriumsmedizin   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Antiphospholipid antibodies; Autoimmune disease; HUVEC; MCP 1; Monocytes; Thrombosis; Tissue factor

Indexed keywords

BETA ACTIN; BETA2 GLYCOPROTEIN 1; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MESSENGER RNA; PARAPROTEIN; PHOSPHOLIPID ANTIBODY; PROCOAGULANT; RECOMBINANT MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT PROTEIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MONOCYTE; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION;

EID: 70049084409     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04632.x     Document Type: Conference Paper

References (26)

1. Hughes, G.R. 1985. The anticardiolipin syndrome. Clin. Exp. Rheumatol. 3: 285-286.
2. Hughes, G.R., E.N. Harris & A.E. Gharavi. 1986. The anticardiolipin syndrome. J. Rheumatol. 13: 486-489.
3. Wilson, W.A., A.E. Gharavi, T. Koike, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42: 1309-1311.
4. Galli, M., T. Barbui, R.F. Zwaal, et al. 1993. Antiphos-pholipid antibodies: involvement of protein cofactors. Haematol. 78: 1-4.
5. Olee, T., S.S. Pierangeli, H.H. Handley, et al. 1996. A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is throm-bogenic in mice. Proc. Natl. Acad. Sci. USA 93: 8606-8611.
6. Pierangeli, S.S., M. Colden-Stanfield, X. Liu, et al. 1999. Antiphospholipid antibodies from antiphos-pholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99: 1997-2002. (Pubitemid 29183897)
7. Vega-Ostertag, M., X. Liu, H. Kwan-Ki, et al. 2006. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br. J. Haematol. 135: 214-219.
8. Van Aken, B.E., 2nd, M. den Heijer, G M.J. Bos, et al. 2000. Recurrent venous thrombosis and markers of inflammation. Thromb. Haemost. 83: 536-539.
9. Franscini, N., E.B. Bachli, N. Blau, et al. 2004. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110: 2903-2909.
10. Lindmark, E. & A. Siegbahn. 2003. Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures. Effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thromb. Res. 108: 77-84.
11. Collins, P.W., K.E. Noble, J.R. Reittie, et al. 1995. Induction of tissue factor expression in human monocyte/endothelium cocultures. Br. J. Haematol. 91: 963-970.
12. Von Landenberg, C., K.J. Lackner, P. von Landen-berg, et al. 1999. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. J. Autoimmun. 13: 215-223.
13. Miyakis, S., M.D. Lockshin, T. Atsumi, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospho-lipid syndrome (APS). J. Thromb. Haemost. 4: 295-306.
14. Zhang, J. & K.R. McCrae. 2005. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-ß2 glycoprotein I antibodies. Blood 105: 1964-1969.
15. Sorice, M., A. Longo, A. Capozzi, et al. 2007. Anti-ß2-Glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 56: 2687-2697.
16. Hunt, J.E., H.P. McNeil, G.J. Morgan, et al. 1992. A phospholipid- ß2-glycoprotein complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1: 75-81.
17. Riboldi, P., M. Gerosa, E. Raschi, et al. 2003. En-dothelium as a target for antiphospholipid antibodies. Immunobiology 207: 29-36.
18. Cho, C.S, M.L. Cho, P.P. Chen, et al. 2002. Antiphos-pholipid antibodies induce monocyte chemoattrac-tant protein-1 in endothelial cells. J. Immunol. 168: 4209-4215.
19. Rollins, B.J. 1996. Monocyte chemoattractant protein-1: a potent regulator of monocyte recruitment in inflammatory disease. Mol. Med. Today 2: 198-204.
20. Gerszten, R.E., E.A. Garcia-Zepeda, Y.C. Lim, et al. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723.
21. Ernofsson, M. & A. Siegbahn. 1996. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb. Res. 83: 307-320.
22. Nojima, J., Y. Masuda, Y. Iwatani, et al. 2008. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem. Biophys. Res. Commun. 365: 195-200.
23. Montiel-Manzano, G., Z. Romay-Penabad, P. de Martinez, et al. 2007. In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies. Ann. N.Y. Acad. Sci. 1108: 540-553.
24. Soltesz, P., H. Der, K. Veres, et al. 2008. Immunolog-ical features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology 47: 1628-1634.
25. Koike, T., M. Bohgaki, O. Amengual & T. Atsumi. 2007. Antiphospholipid antibodies: lessons from the bench. J. Autoimmun. 28: 129-33. Review.
26. De Laat, B., K. Mertens & P. de Groot. 2008. Mechanisms of Disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat. Clin Pract. Rheumatol. 4: 192-199.